Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F. Gainor, Aparna Hegde, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 313-319
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Seroconversion rates following COVID-19 vaccination among patients with cancer
Astha Thakkar, Jesus D. Gonzalez‐Lugo, Niyati Goradia, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1081-1090.e2
Open Access | Times Cited: 341
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
Andrea Becerril‐Gaitan, Bryan F. Vaca‐Cartagena, Ana S. Ferrigno, et al.
European Journal of Cancer (2021) Vol. 160, pp. 243-260
Open Access | Times Cited: 109
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
Marc Peeters, Lise Verbruggen, Laure-Anne Teuwen, et al.
ESMO Open (2021) Vol. 6, Iss. 5, pp. 100274-100274
Open Access | Times Cited: 91
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
Lewis Au, Annika Fendler, Scott Shepherd, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1362-1366
Open Access | Times Cited: 89
Attitudes toward COVID-19 vaccination and willingness to pay: comparison of people with and without mental disorders in China
Fengyi Hao, Bokun Wang, Wanqiu Tan, et al.
BJPsych Open (2021) Vol. 7, Iss. 5
Open Access | Times Cited: 88
Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey
Jing Hong, Xiao-wan Xu, Jing Yang, et al.
Journal of Integrative Medicine (2021) Vol. 20, Iss. 1, pp. 34-44
Open Access | Times Cited: 83
Attitudes of Patients with Cancer towards Vaccinations—Results of Online Survey with Special Focus on the Vaccination against COVID-19
Anna Brodziak, Dawid Sigorski, Małgorzata Osmola, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 411-411
Open Access | Times Cited: 77
Administration of COVID-19 vaccines in immunocompromised patients
Manica Negahdaripour, Mojtaba Shafiekhani, Seyed Mohammad Iman Moezzi, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108021-108021
Open Access | Times Cited: 72
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
Chiara Corti, Gabriele Antonarelli, Florian Scotté, et al.
Annals of Oncology (2021) Vol. 33, Iss. 2, pp. 158-168
Open Access | Times Cited: 71
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
Son Tran, Tony H. Truong, Aru Narendran
European Journal of Cancer (2021) Vol. 159, pp. 259-274
Open Access | Times Cited: 65
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy
Luigi Cavanna, Chiara Citterio, Claudia Biasini, et al.
European Journal of Cancer (2021) Vol. 157, pp. 441-449
Open Access | Times Cited: 48
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment
Tania Buttiron Webber, Nicoletta Provinciali, Marco Musso, et al.
European Journal of Cancer (2021) Vol. 159, pp. 105-112
Open Access | Times Cited: 43
COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
Luigi Cavanna, Chiara Citterio, Ilaria Toscani
Vaccines (2021) Vol. 9, Iss. 9, pp. 1048-1048
Open Access | Times Cited: 42
COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis
K.I.P. Prabani, Ishanka Weerasekara, H. D. W. T. Damayanthi
Public Health (2022) Vol. 212, pp. 66-75
Open Access | Times Cited: 34
Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course
Mengjie Jiang, Yujie Hu, Gang Lin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4191-4191
Open Access | Times Cited: 38
Coronavirus disease 2019 (Covid‐19) vaccination recommendations in special populations and patients with existing comorbidities
Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 37
Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy
Cristina Hagen, Miriam Nowack, Michael Messerli, et al.
Schweizerische medizinische Wochenschrift (2021) Vol. 151, Iss. 2930, pp. w20557-w20557
Open Access | Times Cited: 36
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 35
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
Julius C. Enßle, Julia Campe, Amelie Schwenger, et al.
Blood (2021) Vol. 139, Iss. 1, pp. 137-142
Open Access | Times Cited: 33
Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
Atsushi Sakuraba, Alexander Luna, Dejan Micić
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review
Deniz Can Güven, Taha Koray Şahin, Saadettin Kılıçkap, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28
COVID-19 vaccines in patients with cancer
Dario Trapani, Giuseppe Curigliano
The Lancet Oncology (2021) Vol. 22, Iss. 6, pp. 738-739
Open Access | Times Cited: 25
Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination
Deniz Can Güven, Taha Koray Şahin, Serkan Akın, et al.
The Oncologist (2022) Vol. 27, Iss. 4, pp. e357-e361
Open Access | Times Cited: 17
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
Εfstathia Liatsou, Ioannis Ntanasis‐Stathopoulos, Stavros Lykos, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top